Wyeth Prevnar Vaccine: First Target Group Is 7 Mil. Infants Under Two

Wyeth-Lederle's Prevnar launch in early March will initially be aimed at the approximately 7 mil. children in the U.S. under two years of age and several high-risk and minority populations.